Targeted AntiBiotics for Chronic pulmonary diseases (TARGET ABC): can targeted antibiotic therapy improve the prognosis of Pseudomonas aeruginosa-infected patients with chronic pulmonary obstructive disease, non-cystic fibrosis bronchiectasis, and asthma? A multicenter, randomized, controlled, open-label trial.
Trials. 2022 Sep 27;23(1):817. doi: 10.1186/s13063-022-06720-z.
Trials. 2022.
PMID: 36167555
Free PMC article.
Clinical Trial.